Market revenue in 2024 | USD 706.1 million |
Market revenue in 2030 | USD 2,030.5 million |
Growth rate | 19.4% (CAGR from 2025 to 2030) |
Largest segment | Pre-commercial/ r&d scale |
Fastest growing segment | Commercial Scale |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pre-commercial/ R&D Scale, Commercial Scale |
Key market players worldwide | Miltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.
Pre-commercial/ r&d scale was the largest segment with a revenue share of 88.77% in 2024. Horizon Databook has segmented the North America automated and closed cell therapy processing systems market based on pre-commercial/ r&d scale, commercial scale covering the revenue growth of each sub-segment from 2018 to 2030.
North America is anticipated to witness significant market growth in the automated and closed cell therapy processing systems market due to rising involvement of companies in R&D of cell therapies. The market growth of this region can be attributed to presence of a large number of institutes and centers involved in manufacturing cell therapy.
Moreover, robust government support, presence of key operating players, and strategic initiatives for market expansion are further fueling the market growth. For instance, in June 2020, ThermoGenesis Holdings, Inc. and Corning Incorporated’s Life Sciences Division entered into a global distribution agreement for its X-SERIES products.
In August 2021, Artiva Biopharmaceuticals announced the expansion in the U.S. with a new R&D and manufacturing facility for cell therapies.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America automated and closed cell therapy processing systems market , including forecasts for subscribers. This continent databook contains high-level insights into North America automated and closed cell therapy processing systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account